CeLLogix allogenic bone scaffold
bone allograft containing viable bone-derived cells

CeLLogix cellular bone matrix is a viable allogeneic bone allograft containing viable bone-derived cells

CeLLogix is prepared with a novel DMSO-free cryoprotectant, which provides dependable cell identity and the ability to sustain cell viability post-thaw. Final preparation of the cell and bone components yields a product that provides osteoconductive, osteoinductive, and osteogenic properties to enhance the patient’s innate healing response.
Image

CeLLogix contains the three key elements that are ideal for bone formation

An osteoconductive three-dimensional scaffold with cortical and cancellous components.

A demineralized bone scaffold with osteoinductive potential.¹

Viable spine-derived cells to support osteogenesis.

CeLLogix Product Features

Proprietary, optimized bone microparticulate size range of 100-300 μm²

Novel DMSO-free cryoprotectant, with no rinsing and decanting steps required.

Average cell viability exceeds 80% post-thaw¹

Minimum of 150,000 viable cells per cc of allograft post-thaw¹

Convenient handling and preparation time in the OR

Four hour working window for implantation after thaw without loss of cell viability

Product shelf-life is two years from date of processing when stored at -65°C or colder

Reference:

1. Data on file at VIVEX Biologics, Inc.

2. Malinin, T.I., et. al., Particulate bone allograft incorporation in regeneration of osseous defects; importance of particle sizes. The Open Orthopeadics Journal, 2007. 1:19-24.

Product Brochure

Omnia Medical CeLLogix Product Brochure

Instant Download

Omnia Medical CeLLogix Product Brochure

Download